PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Seed extracts and specific compounds (e.g., garciniaxanthone I, PPAPs) exhibit cytotoxic and anti-proliferative effects against various human cancer cell lines, including hepatocellular carcinoma (HepG2), colon cancer (SW-480), and lung adenocarcinoma (A549) [PMID:36837877, PMID:31569691, PMID:36621652, PMID:15787435].
Bark extracts and specific xanthones (e.g., subelliptenone F and xanthochymusxanthone B) show strong inhibition of alpha-glucosidase and PTP1B [PMID:28624142]. Fruit extracts also demonstrate antidiabetic potential [PMID:35755390, PMID:41063196].
Benzophenones (xanthochymol and garcinol) prevent fungal germ tube emergence and induce hyphal apoptosis [PMID:26195512].
Prenylated xanthones from the wood and methanol extracts enhance nerve growth factor (NGF)-mediated neurite outgrowth in PC12D cells [PMID:14600386, PMID:15235225].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 30000956 (2006) — Antitumor effects and mechanisms of traditional Chinese medicine gamboge: A review. · Frontiers in pharmacology
- 2.PMID: 14600386 (2003) — Prenylated xanthones from Garcinia xanthochymus. · Chemical & pharmaceutical bulletin
- 3.PMID: 36621652 (2023) — Prenylated acylphloroglucinols from the fruits of Garcinia xanthochymus. · Fitoterapia
- 4.PMID: 37154236 (2023) — Comprehensive Metabolite Profiling of Two Edible Garcinia Species Based on UPLC-ESI-QTOF-MSE Coupled with Bioactivity Assays. · Journal of agricultural and food chemistry
- 5.PMID: 36837877 (2023) — Cytotoxic Isopentenyl Phloroglucinol Compounds from Garcinia xanthochymus Using LC-MS-Based Metabolomics.